Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity
Journal of Computer-Aided Molecular Design · 30.07.2026 · 40 (1)
DOI: 10.1007/s10822-026-00903-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computer-Aided Molecular Design, online erschienen am 30.07.2026. Verfasst von Shubham Vishnoi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, SSPC the Research Ireland Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland. Hauptthemen laut MEDLINE: Receptors, Gastrointestinal Hormone, Drug Design, Receptors, Glucagon, Peptides. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Limerick.
Abstract (Originalsprache)
Peptide-based therapeutics such as tirzepatide and semaglutide target the neuroendocrine system to remediate both diabetes and obesity. In addition to integrating the complementary actions of two endogenous metabolically related hormones targeting glucagon-like peptide-1 and glucagon receptors (GLP-1R and GCGR), the synergistic targeting of a third G protein-coupled receptor (GPCR), namely the gastric inhibitory polypeptide receptor (GIPR), may achieve optimal control of blood glucose levels and weight loss in patients with diabetes and obesity. In this work, we harness the predictive power of sequence-derived in silico mutagenesis to rationally design effective single-molecule peptides with triple-receptor-agonist activities. We model the binding profiles of our designed peptides to the GIP, GLP-1 and GCG receptor triad through multiple, long, repeat molecular simulations and effective binding enthalpy calculations to assess their predicted multi-receptor engagement profiles. Our data predict a balanced, highly favourable effective binding enthalpy profile of our newly designed peptides for the three receptors compared to endogenous peptides and the experimental reference peptides, with high targeted specificity for the receptors. The peptides are further engineered to structurally support metabolic stability by substituting sites prone to proteolytic cleavage. The predicted triple-hormone-receptor agonist peptide mechanism opens new avenues for the synthesis and activity testing of multi-targeting peptides with improved stability, offering a computational design strategy for testing the potential reduction of adverse gastrointestinal effects of peptide therapeutics and support future development of lower-dose oral formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physics, SSPC the Research Ireland Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland.
- Department of Chemical Sciences, SSPC the Research Ireland Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland.
- Department of Biological Sciences, SSPC the Research Ireland Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland. shayon.bhattacharya@ul.ie.
- Health Research Institute, University of Limerick, Limerick, V94 T9PX, Ireland. shayon.bhattacharya@ul.ie.
- Department of Physics, SSPC the Research Ireland Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland. damien.thompson@ul.ie.
Förderung
- University of Limerick
Zitieren
APA
Vishnoi, S., Hudson, S., Bhattacharya, S., & Thompson, D. (2026). Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity. Journal of Computer-Aided Molecular Design, 40(1). https://doi.org/10.1007/s10822-026-00903-5
Vancouver
Vishnoi S, Hudson S, Bhattacharya S, Thompson D. Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity. Journal of Computer-Aided Molecular Design. 2026;40(1). doi:10.1007/s10822-026-00903-5
BibTeX
@article{Vishnoi2026,
author = {Vishnoi, Shubham and Hudson, Sarah and Bhattacharya, Shayon and Thompson, Damien},
title = {Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity},
journal = {Journal of Computer-Aided Molecular Design},
year = {2026},
volume = {40},
number = {1},
doi = {10.1007/s10822-026-00903-5}
}
EUVIMED